Search
for
Sort by
Research 481–510 of 1000+
- Diagnosis, Management, and Associated Comorbidities of Polycystic Ovary Syndrome: A Narrative Review
- Periungual lesions secondary to chemotherapy with docetaxel
- Management OF Patients with Polycystic Ovary Syndrom
- Physiopathological role of the enzymatic complex 5α-reductase and 3α/β-hydroxysteroid oxidoreductase in the generation of progesterone and testosterone neuroactive metabolites
- Endocrine evaluation of hirsutism
- What should be kept in mind when treating acne with oral contraceptives? Narrative review
- Il trattamento con metformina e clomifene citrato nelle donne con sindrome dell’ovaio policistico e infertilità
- Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
- Indications for a brain‐hair follicle axis: inhibition of keratinocyte proliferation and up‐regulation of keratinocyte apoptosis in telogen hair follicles by stress and substance P
- Testosterone therapy in women: Myths and misconceptions
- Rabson-Mendenhall syndrome: two case reports and a brief review of the literature
- Testosterone in Women: Measurement and Therapeutic Use
- The clinical spectrum of parathyroid disease
- POLYCYSTIC OVARY SYNDROME: DIVERSE CLINICAL PRESENTATIONS ACROSS ADOLESCENCE, REPRODUCTIVE AGE, AND MENOPAUSE
- Hair Disorders
- STEROID HORMONES IN GERIATRICS
- Synergistic Effects of Cinnamomum zeylanicum and Inositol on Metabolic and Hormonal Parameters in Women with Polycystic Ovary Syndrome
- Syndromes of Severe Insulin Resistance (SSIRs)
- Acne and Systemic Disease
- Harmless Herbs? A Review of the Recent Literature
- Dermatological manifestations associated with pregnancy
- Polycystic ovary syndrome: etiology, pathogenesis and diagnosis
- Androgens and the Menopause
- Sebum Production
- Infertility and teratogenicity after paternal exposure to systemic dermatologic medications: A systematic review
- Metformin: an old medication of new fashion: evolving new molecular mechanisms and clinical implications in polycystic ovary syndrome
- Finasteride
- Testosterone, 17 Ks, 17 beta E2 FSH-LH variations and hirsutism modifications during spironolactone therapy.
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective